Hematology Times
HOME
CME
MEDIA ONDEMAND
EVENTS
ABOUT US
LOGIN
SEARCH
Advanced Search
CME Activities
Comprehensive Overview of ITP
Solving Platelet Dysfunctions and Deficiencies
Targeting FLT3 for treatment of leukemia
Treatment of indolent NHL: The old and the new
The Evolution of Therapeutic Options in ITP
Solving Platelet Dysfunctions and Deficiencies
Title:
Solving Platelet Dysfunctions and Deficiencies in the Era of Thrombopoietin-stimulating Agents
Release Date:
August 1, 2008
Expiration Date:
August 31, 2009
(CME credit is no longer available for this activity)
Originally presented at ASCO 2008
Chicago, IL
May 31, 2008
Agenda:
Changing Landscape of ITP (26:33)
Douglas B. Cines, MD
TPO agents in ITP (31:15)
James B. Bussel, MD
Other disease-associated thrombocytopenias:
Collagen vascular disorders, myelodysplasia,
and liver disease (35:27)
Howard A. Liebman, MD
Supported by an educational grant from:
Jointly Sponsored by:
This program is only available to registered users
If you have already registered, please
click here
to login and continue.
Otherwise, please
click here
to register first.